RUA Life Sciences plc (RUA.L)
GBp 11.0
(0.0%)
GBp 11.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.57 Million GBP | 18.7% |
| 2022 | -1.94 Million GBP | 3.97% |
| 2021 | -2.03 Million GBP | -38.85% |
| 2020 | -1.27 Million GBP | -91.22% |
| 2019 | -703 Thousand GBP | -68.5% |
| 2018 | -391 Thousand GBP | -247.79% |
| 2017 | 185 Thousand GBP | -326.01% |
| 2016 | 42.21 Thousand GBP | 86.32% |
| 2015 | -233.28 Thousand GBP | -2025.58% |
| 2014 | 12.11 Thousand GBP | 104.48% |
| 2013 | -270.57 Thousand GBP | -122.56% |
| 2012 | -573.59 Thousand GBP | 403.9% |
| 2011 | 237.97 Thousand GBP | 114.27% |
| 2010 | -1.66 Million GBP | -9.52% |
| 2009 | -1.61 Million GBP | -64.12% |
| 2008 | -1.23 Million GBP | -9.43% |
| 2007 | -866 Thousand GBP | 52.41% |
| 2006 | -1.83 Million GBP | -407.69% |
| 2005 | -494 Thousand GBP | 79.37% |
| 2004 | -1.91 Million GBP | -17.8% |
| 2003 | -2.55 Million GBP | 94.62% |
| 2002 | 12.82 Million GBP | -970.65% |
| 2001 | 744 Thousand GBP | 162.0% |
| 2000 | -5.59 Million GBP | -276.36% |
| 1999 | -1.39 Million GBP | -80.57% |
| 1998 | -731 Thousand GBP | -108.26% |
| 1997 | -394 Thousand GBP | 78.94% |
| 1996 | -914 Thousand GBP | -1362.28% |
| 1995 | -146 Thousand GBP | 62.5% |
| 1994 | -120 Thousand GBP | -229.36% |
| 1993 | 521 Thousand GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -1.21 Million GBP | 0.0% |
| 2023 FY | - GBP | 18.7% |
| 2023 Q4 | -433 Thousand GBP | 0.0% |
| 2022 FY | - GBP | 3.97% |
| 2022 Q4 | -960 Thousand GBP | 0.0% |
| 2022 Q2 | -1.06 Million GBP | 0.0% |
| 2021 FY | - GBP | -38.85% |
| 2021 Q4 | -907 Thousand GBP | 0.0% |
| 2021 Q2 | -1.19 Million GBP | 0.0% |
| 2020 Q2 | -684 Thousand GBP | 0.0% |
| 2020 Q4 | -874 Thousand GBP | 0.0% |
| 2020 FY | - GBP | -91.22% |
| 2019 Q2 | -152 Thousand GBP | 0.0% |
| 2019 FY | - GBP | -68.5% |
| 2019 Q4 | -609 Thousand GBP | 0.0% |
| 2018 FY | - GBP | -247.79% |
| 2018 Q2 | -144 Thousand GBP | 0.0% |
| 2018 Q4 | -329 Thousand GBP | 0.0% |
| 2017 Q2 | -8000.00 GBP | 0.0% |
| 2017 FY | - GBP | -326.01% |
| 2017 Q4 | -128 Thousand GBP | 0.0% |
| 2016 Q4 | 89.38 Thousand GBP | 0.0% |
| 2016 FY | - GBP | 86.32% |
| 2016 Q2 | -117.25 Thousand GBP | 0.0% |
| 2015 FY | - GBP | -2025.58% |
| 2015 Q4 | -215.23 Thousand GBP | 0.0% |
| 2015 Q2 | -17.18 Thousand GBP | 0.0% |
| 2014 FY | - GBP | 104.48% |
| 2014 Q4 | - GBP | 0.0% |
| 2014 Q2 | 65.34 Thousand GBP | 0.0% |
| 2013 Q2 | -161.2 Thousand GBP | 0.0% |
| 2013 FY | - GBP | -122.56% |
| 2013 Q4 | -113.99 Thousand GBP | 0.0% |
| 2012 Q1 | -438.95 Thousand GBP | 0.0% |
| 2012 FY | - GBP | 403.9% |
| 2012 Q2 | - GBP | 100.0% |
| 2012 Q4 | - GBP | -100.0% |
| 2012 Q3 | 527.26 Thousand GBP | 0.0% |
| 2011 FY | - GBP | 114.27% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | - GBP | 0.0% |
| 2010 Q2 | - GBP | 0.0% |
| 2010 FY | - GBP | -9.52% |
| 2010 Q4 | - GBP | 0.0% |
| 2009 Q4 | - GBP | 0.0% |
| 2009 FY | - GBP | -64.12% |
| 2009 Q2 | - GBP | 0.0% |
| 2008 Q2 | - GBP | 0.0% |
| 2008 FY | - GBP | -9.43% |
| 2008 Q4 | - GBP | 0.0% |
| 2007 Q4 | - GBP | 0.0% |
| 2007 FY | - GBP | 52.41% |
| 2007 Q2 | - GBP | 0.0% |
| 2006 FY | - GBP | -407.69% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | - GBP | 79.37% |
| 2005 Q2 | - GBP | 0.0% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 FY | - GBP | -17.8% |
| 2004 Q4 | - GBP | 0.0% |
| 2003 FY | - GBP | 94.62% |
| 2003 Q4 | - GBP | 0.0% |
| 2003 Q2 | - GBP | 0.0% |
| 2002 FY | - GBP | -970.65% |
| 2001 FY | - GBP | 162.0% |
| 2000 FY | - GBP | -276.36% |
| 1999 FY | - GBP | -80.57% |
| 1998 FY | - GBP | -108.26% |
| 1997 FY | - GBP | 78.94% |
| 1996 FY | - GBP | -1362.28% |
| 1995 FY | - GBP | 62.5% |
| 1994 FY | - GBP | -229.36% |
| 1993 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|